| dc.contributor.author | Aksoy, E | |
| dc.contributor.author | Gungor, S | |
| dc.contributor.author | Agca, MC | |
| dc.contributor.author | Ozmen, I | |
| dc.contributor.author | Duman, D | |
| dc.contributor.author | Kocak, ND | |
| dc.contributor.author | Akturk, UA | |
| dc.contributor.author | Tuncay, E | |
| dc.contributor.author | Salturk, C | |
| dc.contributor.author | Yalcinsoy, M | |
| dc.contributor.author | Ocakli, B | |
| dc.contributor.author | Karakurt, Z | |
| dc.date.accessioned | 2022-08-17T12:52:12Z | |
| dc.date.available | 2022-08-17T12:52:12Z | |
| dc.date.issued | 2018 | |
| dc.identifier.uri | http://hdl.handle.net/11616/61050 | |
| dc.description.abstract | OBJECTIVES: The choice of treatment according to the inflammation type in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has been of recent interest. This study investigated the role of novel biomarkers, hospital outcomes, and readmission rates in the first month in patients with eosinophilic or neutrophilic AECOPD. | |
| dc.source | TURKISH THORACIC JOURNAL | |
| dc.title | A Revised Treatment Approach for Hospitalized Patients with Eosinophilic | |
| dc.title | and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease |
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||